Surescripts named an outsider, Frank Harvey, as its CEO, the e-prescription company said Monday.
Harvey, who most recently led private-equity investments for healthcare technology companies at ATLS Investments, will take the helm June 27. He succeeds Tom Skelton, who in November announced plans to retire.
Before ATLS Investments, Harvey served as CEO of Mirixa, a technology company focused on medication therapy management that was acquired by Cardinal Health, and as CEO of Liberty Medical Supply, a company that sells prescription drugs and other medical supplies.
“Frank is a results-oriented leader with strong operational skills, and extensive experience growing healthcare businesses,” said Douglas Hoey, co-chair of Surescripts’ board of directors, in a news release.
Harvey in a news release said he plans to launch new products and services at Surescripts.
Arlington, Virginia-based Surescripts is a privately held health information exchange network best known for routing electronic prescriptions between healthcare providers and pharmacies. It also develops prior authorization, medication history and other tools for health systems, health plans, pharmacy benefit managers, pharmacies and other technology vendors.
Nearly 1.9 million healthcare professionals completed 20.4 billion transactions on the Surescripts network last year, up 16.6% from 2020, according to the company.
The company is defending itself in a lawsuit brought by the Federal Trade Commission in 2019 in the U.S. District Court in Washington. In the complaint, the FTC alleges Surescripts has monopolized portions of the e-prescription market.
Skelton, who joined Surescripts as CEO in 2014, said he would work with the new CEO during a transition period.